Sophia Finckbone GSK

Sophia Finckbone is the Global Process Owner of Deviations and CAPA for the GSK Global Supply Chain. She is a data-driven, passionate investigator with a desire to understand the key influences of human behaviour. In her role, Sophia provides expertise, guidance and oversight of the Deviations, RCA, and CAPA processes. She collaborates with Medicines, Vaccines, and R&D units to drive community engagement and standardization of processes.

Previous to this, Sophia was the Operational Quality Manager for a GSK Consumer Healthcare (now Haleon) manufacturing site where she was responsible for quality oversight of operations, batch release, and deviations.

Before joining GSK in 2016, Sophia was the Quality Assurance Manager of the Siteman Cancer Center’s Tissue Procurement Core. Here, she provided analytical oversight and deployment of a QMS to support the biorepository’s CAP accreditation. In her early career, Sophia was the Manufacturing Supervisor at ISTO Biologics (formerly ISTO Technologies, Inc.) where her experience led to “Cell Expansion Methods and Systems” patent publication with colleagues.

Sophia holds a BS in Organismal Biology from the University of Kansas and is accredited in Leading CI through Lancaster University. She resides in the Greater St. Louis area and enjoys spending time with her family and children.